CADTH | Evidence Driven
CADTH | Evidence Driven

Drug Reimbursement Recommendation - Botox

Today, CADTH has issued final recommendations for:

onabotulinumtoxinA (Botox)

Indications: Migraine, chronic
Recommendation: Reimburse with clinical criteria and/or conditions

For more information

Last Updated : October 22, 2019